Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682968 · ClinicalTrials.gov registry record
Evidence Synthesis: Hypertension Medication Adherence & Intensification
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 20
- Enrollment target
NCT00682968: Completed study, sponsored by VA Office of Research and Development.
NCT00682968 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00682968 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Hypertension affects nearly 50 million Americans \[1\] and is the most common chronic condition among veterans. Unfortunately, many patients with established hypertension have poorly controlled blood pressure (BP); control rates in the VA are at approximately 70% currently. While clinician failure to aggressively manage hypertension through therapeutic intensification (clinical inertia, or failure to intensify pharmacotherapy appropriately) contributes to poor blood pressure control, even when doctors do intensify therapy, 43-78% of patients fail to adhere to recommended therapies, indicating that adherence remains a central problem in hypertension care. This suggests important opportunities for interventions to improve risk factor control by working through clinicians, their teams, or their delivery systems, as well as with patients, to address both patient adherence and clinical inertia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-07-20 |
| Est. Completion | 2008-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00682968
The ClinicalTrials.gov registry entry for NCT00682968 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00682968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00682968 about?
NCT00682968 is a clinical study titled "Evidence Synthesis: Hypertension Medication Adherence & Intensification". Hypertension affects nearly 50 million Americans \[1\] and is the most common chronic condition among veterans. Unfortunately, many patients with established hypertension have poorly controlled blood pressure (BP); control rates in the VA are at approximately 70% currently. While clinician failure t...
What is the current status of trial NCT00682968?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-07-20. Estimated completion is 2008-10-01.
Who is sponsoring clinical trial NCT00682968?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.